At DrNose, we are redefining early disease detection with an innovative Electronic Nose that analyses human breath to identify cancers and chronic diseases in real time. Our non-intrusive, low-cost device uses just six precisely selected sensors to detect complex chemical patterns that indicate illness—something previously possible only with expensive lab equipment.

Backed by two decades of R&D, our technology has already demonstrated success in clinical trials for breast and lung cancers, achieving highly accurate results. Combining expertise in AI, smell sensing, chemical engineering, and electronics, we are now expanding our focus to a broader range of diseases, driven by ongoing clinical trials and commercialization efforts.

With the potential to make early diagnosis affordable and accessible, DrNose aims to transform preventive healthcare, save billions in treatment costs, and ultimately help people live longer, healthier lives.

DrNose.ai

Org chart

Teams

Offices